Cook P W, Edwards C P, Haraguchi T, Firestone G L
Department of Molecular and Cell Biology, University of California, Berkeley 94720.
J Biol Chem. 1989 Aug 25;264(24):14151-8.
We have previously shown that glucocorticoids suppress the proliferation of Fu5 hepatoma cells and have selected subclones which are either hypersensitive (BDS1) or resistant (EDR3) to the antiproliferative effects of dexamethasone, a synthetic glucocorticoid. BDS1 cells externalize a glucocorticoid suppressible mitogenic activity (denoted GSM) which stimulated [3H]thymidine incorporation in quiescent, serum-starved Balb/c 3T3 cells. Glucocorticoid treatment of BDS1 cells reduced the secreted levels of GSM activity by approximately 20-fold in comparison to untreated cells. The GSM activity was constitutively secreted from a glucocorticoid receptor minus variant (EDR3) demonstrating that the suppression of this mitogenic activity is a new glucocorticoid hormone response which required a functional receptor. GSM activity was sensitive to sulfhydryl reducing agents or trypsin, stable to heat and acid treatments and fractionated in gel filtration columns with a native molecular weight of approximately Mr 30,000. The persistence of this size for mitogenic activity after electrophoretic fractionation in nonreducing sodium dodecyl sulfate-poly-acrylamide gels suggested that the GSM activity is comprised of a single protein. Total secreted protein isolated from untreated BDS1, but not dexamethasone-treated BDS1, stimulated 3T3 cells to grow in transformed-appearing large colonies in soft agar and to display multiple layering and elongated spindle-like morphology on solid substratum. The addition of both insulin and EGF to conditioned medium protein isolated from glucocorticoid-treated BDS1 cells restored full induction of 3T3 cell anchorage-independent growth while insulin restored full and EGF partial mitogenic stimulation of these fibroblasts. These results suggest that the GSM activity acts in a pathway common to that of insulin or EGF in fibroblasts.
我们之前已经表明,糖皮质激素可抑制Fu5肝癌细胞的增殖,并筛选出了对地塞米松(一种合成糖皮质激素)的抗增殖作用高度敏感(BDS1)或具有抗性(EDR3)的亚克隆。BDS1细胞可释放一种糖皮质激素可抑制的促有丝分裂活性(称为GSM),该活性可刺激静止的、血清饥饿的Balb/c 3T3细胞掺入[3H]胸腺嘧啶核苷。与未处理的细胞相比,用糖皮质激素处理BDS1细胞可使GSM活性的分泌水平降低约20倍。GSM活性由糖皮质激素受体缺失变体(EDR3)组成性分泌,这表明这种促有丝分裂活性的抑制是一种新的糖皮质激素反应,需要功能性受体。GSM活性对巯基还原剂或胰蛋白酶敏感,对热和酸处理稳定,在凝胶过滤柱中分级分离时,其天然分子量约为30,000 Mr。在非还原十二烷基硫酸钠-聚丙烯酰胺凝胶中进行电泳分级分离后,这种促有丝分裂活性的大小持续存在,这表明GSM活性由单一蛋白质组成。从未处理的BDS1而非地塞米松处理的BDS1中分离出的总分泌蛋白,可刺激3T3细胞在软琼脂中形成转化样的大菌落生长,并在固体基质上呈现多层和细长的纺锤状形态。将胰岛素和表皮生长因子(EGF)添加到从糖皮质激素处理的BDS1细胞中分离的条件培养基蛋白中,可恢复3T3细胞锚定非依赖性生长的完全诱导,而胰岛素可恢复这些成纤维细胞的完全促有丝分裂刺激,EGF则部分恢复。这些结果表明,GSM活性在成纤维细胞中与胰岛素或EGF的共同途径中起作用。